Murine syngeneic tumor lines expressing SIY were categorized as ‘progressor’ or ‘regressor,’ and implanted in wild-type, Rag2-/-, Batf3-/-, Clec9aGFP/GFP, and CD11c-DTR bone marrow (BM) chimera mice. Here, ITGAX is linked to neoplasm.